Literature DB >> 22115823

Sublingual buprenorphine in acute pain management: a double-blind randomized clinical trial.

Mohammad Jalili1, Marzieh Fathi, Maziar Moradi-Lakeh, Shahriar Zehtabchi.   

Abstract

STUDY
OBJECTIVE: We compare the efficacy and safety of sublingual buprenorphine versus intravenous morphine sulfate in emergency department adults with acute bone fracture.
METHODS: Enrolled patients received buprenorphine 0.4 mg sublingually or morphine 5 mg intravenously in this double-blind, double-dummy, randomized controlled trial. Patients graded their pain with a standard 11-point numeric rating scale before medication administration and 30 and 60 minutes after, and we recorded adverse reactions.
RESULTS: We analyzed 44 and 45 patients in the buprenorphine and morphine groups, respectively. Mean pain scores were similar at 30 minutes (5.0 versus 5.0; difference 0; 95% confidence interval -0.6 to 0.8) and at 60 minutes (2.2 versus 2.2; difference 0; 95% confidence interval -0.3 to 0.3). Adverse effects observed within 30 minutes were nausea (14% versus 12%), dizziness (14% versus 22%), and hypotension (4% versus 18%).
CONCLUSION: For adults with acute fractures, buprenorphine 0.4 mg sublingually is as effective and safe as morphine 5 mg intravenously.
Copyright © 2011. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22115823     DOI: 10.1016/j.annemergmed.2011.10.021

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  9 in total

1.  Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.

Authors:  Perrine Roux; Maria A Sullivan; Julien Cohen; Lionel Fugon; Jermaine D Jones; Suzanne K Vosburg; Ziva D Cooper; Jeanne M Manubay; Shanthi Mogali; Sandra D Comer
Journal:  Pain       Date:  2013-05-07       Impact factor: 6.961

2.  The effect of preoperative sublingual buprenorphine on postoperative pain after lumbar discectomy: A randomized controlled trial.

Authors:  Farshad Hassanzadeh Kiabi; Seyed Abdollah Emadi; Misagh Shafizad; Abdolmajid Gholinataj Jelodar; Hojat Deylami
Journal:  Ann Med Surg (Lond)       Date:  2021-05-01

3.  Sublingual buprenorphine for acute renal colic pain management: a double-blind, randomized controlled trial.

Authors:  Pooya Payandemehr; Mohammad Jalili; Babak Mostafazadeh Davani; Ahmad Reza Dehpour
Journal:  Int J Emerg Med       Date:  2014-01-03

4.  Impact of age, sex and route of administration on adverse events after opioid treatment in the emergency department: a retrospective study.

Authors:  Raoul Daoust; Jean Paquet; Gilles Lavigne; Éric Piette; Jean-Marc Chauny
Journal:  Pain Res Manag       Date:  2015 Jan-Feb       Impact factor: 3.037

Review 5.  Essential pharmacologic options for acute pain management in the emergency setting.

Authors:  David H Cisewski; Sergey M Motov
Journal:  Turk J Emerg Med       Date:  2018-12-10

6.  Intranasal sufentanil versus intravenous morphine for acute severe trauma pain: A double-blind randomized non-inferiority study.

Authors:  Marc Blancher; Maxime Maignan; Cyrielle Clapé; Jean-Louis Quesada; Roselyne Collomb-Muret; François Albasini; François-Xavier Ageron; Stephanie Fey; Audrey Wuyts; Jean-Jacques Banihachemi; Barthelemy Bertrand; Audrey Lehmann; Claire Bollart; Guillaume Debaty; Raphaël Briot; Damien Viglino
Journal:  PLoS Med       Date:  2019-07-16       Impact factor: 11.069

7.  Sublingual Buprenorphine Efficacy in Renal Colic Pain Relief: A Randomized Placebo-Controlled Clinical Trial.

Authors:  Javad Mozafari; Kambiz Masoumi; Arash Forouzan; Hassan Motamed; Malehi Amal Saki; Marzieh Dezham
Journal:  Pain Ther       Date:  2017-10-20

8.  A Comparison of Metoclopramide and Ondansetron Efficacy for the Prevention of Nausea and Vomiting In Patients Suffered From Renal Colic.

Authors:  Abolfazl Jokar; Peyman Khademhosseini; Koroosh Ahmadi; Alireza Sistani; Mohammad Amiri; Arash Gorji Sinaki
Journal:  Open Access Maced J Med Sci       Date:  2018-10-18

9.  Complete opioid transition to sublingual Buprenorphine after abdominal surgery is associated with significant reductions in opioid requirements, but not reduction in hospital length of stay: a retrospective cohort study.

Authors:  Charlotte Heldreich; Sameer Ganatra; Zheng Lim; Ilonka Meyer; Raymond Hu; Laurence Weinberg; Chong O Tan
Journal:  BMC Anesthesiol       Date:  2022-01-21       Impact factor: 2.217

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.